• 1
    National Cancer Institute. Eliminating Tobacco-Related Health Disparities Summary Report. US Department of Health and Human Services, National Institutes of Health, Bethesda, MD: NIH Publication No. 05-5283; April 2005.
  • 2
    Baquet C. R., Carter-Pokras O., Bengen-Seltzer B. Healthcare disparities and models for change. Am J Manag Care 2004; 10: SP511.
  • 3
    U.S. Office of Management and Budget. Revisions to the Standards for the Classification of Federal Data on Race and Ethnicity, 1997. Available at: (accessed 26 May 2006).
  • 4
    Maddox Y., Fauci A., Ruffin J. NIH Strategic Research Plan to Reduce and Ultimately Eliminate Health Disparities 2002–2006. Washington, DC: Draft, 2006.
  • 5
    Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academy of Sciences, National Research Council; 2002.
  • 6
    Robinson R. G. Community development model for public health applications: overview of a model to eliminate population disparities. Health Promot Pract 2005; 6: 33846.
  • 7
    Agency for Healthcare Research and Quality. Web-Enabled 2005 National Healthcare Disparities Report (NHDR),2005. Available at: (accessed 26 May 2007).
  • 8
    Fagan P., King G., Lawrence D., Petrucci S. A., Robinson R. G., Banks D. et al. Eliminating tobacco-related health disparities: directions for future research. Am J Public Health 2004; 94: 21117.
  • 9
    U.S. Department of Health and Human Services. Tobacco Use Among U.S. Racial/Ethnic Minority Groups: A Report of the Surgeon General. National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. Washington, DC: Centers for Disease Prevention and Control; 1998.
  • 10
    National Cancer Institute. Risks Associated with Smoking Cigarettes and Low Machine-Measured Yields of Tar and Nicotine. Smoking and Tobacco Control, Monograph No. 13, Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, 2001.
  • 11
    DSM-IV-TR. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington DC: American Psychiatric Association; 2000.
  • 12
    Krieger N. Defining and investigating social disparities in cancer: critical issues. Cancer Cause Control 2005; 16: 514.
  • 13
    Adler N. E., Newman K. Socioeconomic disparities in health: pathways and policies. Health Aff 2002; 21: 6076.
  • 14
    LaVeist T. A. Disentangling race and socioeconomic status: a key to understanding health inequalities. J Urban Health 2005; 82: iii2634.
  • 15
    Buka S. L. Disparities in health status and substance use: ethnicity and socioeconomic factors. Public Health Rep 2002; 117: S11825.
  • 16
    Wyatt S. B., Williams D. R., Calvin R., Henderson F. C., Walker E. R., Winters K. Racism and cardiovascular disease in African Americans. Am J Med Sci 2003; 325: 31531.
  • 17
    Clark R., Anderson N. B., Clark V. R., Williams D. R. Racism as a stressor for African Americans: a biological model. Am Psychol 1999; 54: 80516.
  • 18
    Jackson J. S. Race and Ethnic Differences in Physical and Mental Health Disparities. Bethesda, MD: Division of Epidemiology Services and Prevention Research Seminar Series, National Institute on Drug Abuse; 2004.
  • 19
    Barker D. J. P. Mothers, Babies, and Health in Later Life. London: Churchill Livingstone; 1998.
  • 20
    Costa D. L. Changing chronic disease rates and long-term declines in functional limitation among older men. Demography 2002; 39: 11937.
  • 21
    Hayward M. D., Crimmins E. M., Miles T. P., Yu Y. The significance of socioeconomic status in explaining the racial gap in chronic health conditions. Am Sociol Rev 2000; 65: 91030.
  • 22
    Kuh D., Ben-Shlomo B. A Life Course Approach to Chronic Disease Epidemiology. New York: Oxford University Press; 1997.
  • 23
    Whitlock E. P., Orleans C. T., Pender N., Allan J. Evaluating primary care behavioral counseling interventions: an evidence-based approach. Am J Prev Med 2002; 22: 26784.
  • 24
    Johnson R. L., Roter D., Powe N. R., Cooper L. A. Patient race/ethnicity and quality of patient-physician communication during medical visits. Am J Public Health 2004; 94: 208490.
  • 25
    Woods M. N., Harris K. J., Mayo M. S., Catley D., Scheibmeir M., Ahluwalia J. S. Participation of African Americans in a smoking cessation trial: a quantitative and qualitative study. J Natl Med Assoc 2002; 94: 60918.
  • 26
    Wendler D., Kington R., Madans J., Wye G. V., Christ-Schmidt H., Pratt L. A. et al. Are racial and ethnic minorities less willing to participate in health research? PLoS Med 2005; 3: e19.
  • 27
    Moffat S., White M., Mackintosh J., Howel D. Using quantitative and qualitative data in health services research—what happens when mixed method findings conflict? Health Serv Res 2006; 6: 28.
  • 28
    Anthony J. C., Warner L. A., Kessler R. C. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey. Exp Clin Psychopharm 1994; 3: 24468.
  • 29
    Fiore M. C. U.S. public health service clinical practice guideline: treating tobacco use and dependence. Respir Care 2000; 45: 120062.
  • 30
    World Bank. Curbing the Epidemic: Governments and the Economics of Tobacco Control. Washington, DC: World Bank; 1999.
  • 31
    Moolchan E. T., Radzius A., Epstein D. H., Uhl G., Gorelick D. A., Cadet J. L. et al. The Fagerström Test for Nicotine Dependence and the diagnostic interview schedule: do they diagnose the same smokers? Addict Behav 2002; 27: 10113.
  • 32
    Colby S. M., Tiffany S. T., Shiffman S., Niaura R. S. Are adolescent smokers dependent on nicotine? A review of the evidence. Drug Alcohol Depend 2000; 59: S8395.
  • 33
    Mazas C. A., Wetter D. W. Smoking cessation interventions among African Americans: research needs. Cancer Control 2003; 10: 879.
  • 34
    National Action Plan for Tobacco Cessation Subcommittee on Cessation. Interagency Committee on Smoking and Health; February 13, 2003.
  • 35
    Chassin L., Presson C. C., Sherman S. J., Edwards D. A. The natural history of cigarette smoking: predicting young-adult smoking outcomes from adolescent smoking patterns. Health Psychol 1990; 9: 70116.
  • 36
    Stanton W. R. DSM-III-R tobacco dependence and quitting during late adolescence. Addict Behav 1995; 20: 595603.
  • 37
    U.S. Department of Health and Human Services. PHS Preventing Tobacco Use Among Young People: A Report of the Surgeon General (S/N 017-001-00491-0). Washington, DC: US Government Printing Office; 1994.
  • 38
    Trinidad P. R., Gilpin E. A., Lee L., Pierce J. P. Do the majority of Asian-American and African-American smokers start as adults? Am J Prev Med 2004; 26: 1568.
  • 39
    Heatherton T. F., Kozlowski L. T., Frecker R. C., Fagerström K. O. The Fagerström Test for Nicotine Dependence: a revision of the fagerström tolerance questionnaire. Br J Addict 1991; 86: 111927.
  • 40
    Storr C. L., Reboussin B. A., Anthony J. C. The Fagerström Test for Nicotine Dependence: a comparison of standard scoring and latent class analysis approaches. Drug Alcohol Depend 2005; 80: 24150.
  • 41
    Schroeder J. R., Moolchan E. T. Ethnic differences among adolescents seeking smoking cessation treatment: a structural analysis of responses on the Fagerström Test for Nicotine Dependence. Nicotine Tob Res 2007; 9: 13745.
  • 42
    Ernst M., Moolchan E. T., Robinson M. L. Behavioral and neural consequences of prenatal exposure to nicotine. J Am Acad Child Psychiatry 2001; 40: 63041.
  • 43
    Jamner L. D., Whalen C. K., Loughlin S. E., Mermelstein R., Audrain-McGovern J., Krishnan-Sarin S. et al. Tobacco use across the formative years: a road map to developmental vulnerabilities. Nicotine Tob Res 2003; 5: S7187.
  • 44
    Kandel D. B., Chen K. Extent of smoking and nicotine dependence in the United States: 1991–1993. Nicotine Tob Res 2000; 2: 26374.
  • 45
    Moolchan E. T., Aung A. T., Henningfield J. E. Treatment of adolescent tobacco smokers: issues and opportunities for exposure reduction approaches. Drug Alcohol Depend 2003; 70: 22332.
  • 46
    Mayhew K. P., Flay B. R., Mott J. A. Stages in the development of adolescent smoking. Drug Alcohol Depend 2000; 59: s6181.
  • 47
    Chaloupka F. J., Pacula R. L. Sex and race differences in young people's responsiveness to price and tobacco control policies. Tob Control 1999; 8: 3737.
  • 48
    Shiffman S. Tobacco ‘chippers’—individual differences in tobacco dependence. Psychopharmacology 1989; 97: 53947.
  • 49
    Chaloupka F. J. Contextual factors and youth tobacco use: policy linkages. Addiction 2003; 98: 1479.
  • 50
    Nichter M. Smoking: what does culture have to do with it? Addiction 2003; 98: 13945.
  • 51
    Unger J. B. Peers, family, media, and adolescent smoking: ethnic variation in risk factors in a national sample. Adolesc Fam Health 2003; 3: 6570.
  • 52
    White H. R., Nagin D., Replogle E., Stouthamer-Loeber M. Racial differences in trajectories of cigarette use. Drug Alcohol Depend 2004; 76: 21927.
  • 53
    Everitt B. J., Robbins T. W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 2005; 8: 14819.
  • 54
    Kendler K. S., Neale M. C., Sullivan P., Corey L. A., Gardner C. O., Prescott C. A. A population-based twin study in women of smoking initiation and nicotine dependence. Psychol Med 1999; 29: 299308.
  • 55
    McNeill A. D., West R. J., Jarvis M., Jackson P., Bryant A. Cigarette withdrawal symptoms in adolescent smokers. Psychopharmacology 1986; 90: 5336.
  • 56
    Pianezza M. L., Sellers E. M., Tyndale R. F. Nicotine metabolism defect reduces smoking. Nature 1998; 393: 750.
  • 57
    Glassman A. H., Helzer J. E., Covey L. S., Cottler L. B., Stetner F., Tipp J. E. et al. Smoking, smoking cessation, and major depression. J Am Med Assoc 1990; 264: 15469.
  • 58
    Rohde P., Kahler C. W., Lewinsohn P. M., Brown R. A. Psychiatric disorders, familial factors, and cigarette smoking. II. Associations with progression to daily smoking. Nicotine Tob Res 2004; 6: 11932.
  • 59
    Nezami E., Unger J., Tan S., Mahaffey C., Ritt-Olson A., Sussman S. et al. The influence of depressive symptoms on experimental smoking and intention to smoke in a diverse youth sample. Nicotine Tob Res 2005; 7: 2438.
  • 60
    Robinson M. L., Berlin I., Moolchan E. T. Tobacco smoking trajectory and associated ethnic differences among adolescent smokers seeking cessation treatment. J Adolesc Health 2004; 35: 21724.
  • 61
    Ellickson P. L., Morton S. C. Identifying adolescents at risk for hard drug use: racial/ethnic variations. J Adolesc Health 1999; 25: 38295.
  • 62
    Breslau N., Peterson E. L. Smoking cessation in young adults: age at initiation of cigarette smoking and other suspected influences. Am J Public Health 1996; 86: 21420.
  • 63
    Khuder S. A., Dayal H. H., Mutgi A. B. Age at smoking onset and its effect on smoking cessation. Addict Behav 1999; 24: 6737.
  • 64
    Lando H. A., Thai D. T., Murray D. M., Robinson L. A., Jeffery R. W., Sherwood N. E. et al. Age of initiation, smoking patterns, and risk in a population of working adults. Prev Med 1999; 29: 5908.
  • 65
    Henningfield J. E., Moolchan E. T., Zeller M. Regulatory strategies to reduce tobacco addiction in youth. Tob Control 2003; 12: I1424.
  • 66
    Breslau N., Johnson E. O. Predicting smoking cessation and major depression in nicotine-dependent smokers. Am J Public Health 2000; 90: 11227.
  • 67
    King G., Polednak A. P., Bendel R., Hovey D. Cigarette smoking among native and foreign-born African Americans. Ann Epidemiol 1999; 9: 23644.
  • 68
    Haiman C. A., Stram D. O., Wilkens L. R., Pike M. C., Kolonel L. N., Henderson B. E. et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med 2006; 354: 33342.
  • 69
    O'Loughlin J., Paradis G., Kim W., DiFranza J., Meshefedjian G., McMillan-Davey E. et al. Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers. Tob Control 2004; 13: 4228.
  • 70
    Tyndale R. F., Sellers E. M. Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior. Ther Drug Monit 2002; 24: 16371.
  • 71
    Benowitz N. L., Perez-Stable E. J., Fong I., Modin G., Herrera B., Jacob P. III Ethnic differences in N-glucuronidation of nicotine and cotinine. J Pharmacol Exp Ther 1999; 291: 1196203.
  • 72
    Moolchan E. T., Franken F. H., Jaszyna-Gasior M. Adolescent nicotine metabolism: ethnoracial differences among dependent smokers. Ethn Dis 2006; 16: 23945.
  • 73
    Velicer W. F., Prochaska J. O. An expert system intervention for smoking cessation. Patient Educ Couns 1999; 36: 11929.
  • 74
    Anthonisen N. R., Skeans M. A., Wise R. A., Manfreda J., Kanner R. E., Connett J. E. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005; 142: 2339.
  • 75
    Samet J. M. Health benefits of smoking cessation. Clin Chest Med 1991; 12: 66979.
  • 76
    Hajek P., Stead L., West R., Jarvis M. Relapse prevention interventions for smoking cessation. Cochrane Database Syst Rev 2005; 25: CD003999.
  • 77
    Hughes J. R., Keely J. P., Niaura R. S., Ossip-Klein D. J., Richmond R. L., Swan G. E. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res 2003; 5: 1325.
  • 78
    Stratton K., Shetty P., Wallace R., Bondurant S. Clearing the smoke: the science base for tobacco harm reduction—executive summary. Tob Control 2001; 10: 18995.
  • 79
    McLeroy K. R., Bibeau D., Steckler A., Glanz L. An ecological perspective on health promotion programs. Health Educ Q 1998; 15: 35177.
  • 80
    Aquilino M. L., Lowe J. B. Approaches to tobacco control: the evidence base. Eur J Dent Educ 2004; 8: 1117.
  • 81
    Hughes J. R., Shiffman S., Callas P., Zhang J. A meta-analysis of the efficacy of over-the-counter nicotine replacement. Tob Control 2003; 12: 217.
  • 82
    Velicer W. F., Keller S., Friedman R. H., Fava J. L., Gulliver S. B., Ward R. M. et al. Comparing participants and nonparticipants recruited for an effectiveness study of nicotine replacement therapy. Ann Behav Med 2005; 29: 18191.
  • 83
    Fiore M. C., McCarthy D. E., Jackson T. C., Zehner M. E., Jorenby D. E., Mielke M. et al. Integrating smoking cessation treatment into primary care: an effectiveness study. Prev Med 2004; 38: 41220.
  • 84
    Curry S. J., Ludman E. J., McClure J. Self-administered treatment for smoking cessation. J Clin Psychol 2003; 59: 30519.
  • 85
    Lichtenstein E., Glasgow R. E., Lando H. A., Ossip-Klein D. J., Boles S. M. Telephone counseling for smoking cessation: rationales and meta-analytic review of evidence. Health Educ Res 1996; 11: 24357.
  • 86
    Rabius V., McAlister A. L., Geiger A., Huang P., Todd R. Telephone counseling increases cessation rates among young adult smokers. Health Psychol 2004; 23: 53941.
  • 87
    Velicer W. F., Prochaska J. O., Redding C. A. Tailored communications for smoking cessation: past successes and future directions. Drug Alcohol Rev 2006; 25: 4755.
  • 88
    H.R. 1108 109th Congress S. Family Smoking Prevention and Tobacco Control Act; 2007.
  • 89
    Hatsukami D. K., Henningfield J. E., Kotlyar M. Harm reduction approaches to reducing tobacco-related mortality. Annu Rev Public Health 2004; 25: 37795.
  • 90
    Warner K. E., Peck C. C., Woosley R. L., Henningfield J. E., Slade J. Treatment of tobacco dependence: innovative regulatory approaches to reduce death and disease: preface. Food Drug Law J 1998; 53: 18.
  • 91
    Prochaska J. O., Velicer W. F., Rossi J. S., Redding C. A., Greene G. W., Rossi S. R. et al. Multiple risk expert systems interventions: impact of simultaneous stage-matched expert system interventions for smoking, high-fat diet, and sun exposure in a population of parents. Health Psychol 2004; 23: 50316.
  • 92
    Taylor C. B., Curry S. J. Implementation of evidence-based tobacco use cessation guidelines in managed care organizations. Ann Behav Med 2004; 27: 1321.
  • 93
    Fu S. S., Sherman S. E., Yano E. M., Van Ryn M., Lanto A. B., Joseph A. M. Ethnic disparities in the use of nicotine replacement therapy for smoking cessation in an equal access health care system. Am J Health Promot 2005; 20: 10816.
  • 94
    Prochaska J. O., DiClemente C. C. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 1983; 51: 3905.
  • 95
    Shiffman S., Gitchell J., Pinney J. M., Burton S. L., Kemper K. E., Lara E. A. Public health benefit of over-the-counter nicotine medications. Tob Control 1997; 6: 30610.
  • 96
    Shiffman S., Rolf C. N., Hellebusch S. J., Gorsline J., Gorodetzky C. W., Chiang Y. K. et al. Real-world efficacy of prescription and over-the-counter nicotine replacement therapy. Addiction 2002; 97: 50516.
  • 97
    Thorndike A. N., Biener L., Rigotti N. A. Effect on smoking cessation of switching nicotine replacement therapy to over-the-counter status. Am J Public Health 2002; 92: 43742.
  • 98
    Stone E. G., Morton S. C., Hulscher M. E., Maglione M. A., Roth E. A., Grimshaw J. M. et al. Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Ann Intern Med 2002; 136: 64151.
  • 99
    Bodenheimer T., Wagner E. H., Grumbach K. Improving primary care for patients with chronic illness. J Am Med Assoc 2002; 288: 17759.
  • 100
    Rust G., Fryer G. E. Jr, Phillips R. L. Jr, Daniels E., Strothers H., Satcher D. Modifiable determinants of healthcare utilization within the African-American population. J Natl Med Assoc 2004; 96: 116977.